Emily Gard Marshall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily Gard Marshall has a total of 408 co-authors. Here are the top co-authors by number of shared publications:
- Maria Mathews
Department of Family Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada
17 shared publications - Miriam Ruth Lavergne
Department of Family Medicine, Faculty of Medicine, Dalhousie University, Halifax, Canada
11 shared publications Richard Buote
Primary Care Research Unit, Dalhousie Family Medicine, Dalhousie University, Halifax, NS, Canada
11 shared publicationsMaria Mathews
Department of Family Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada
9 shared publicationsMelissa K. Andrew
9 shared publications- Lauren Moritz
Dalhousie University, Halifax, Nova Scotia, Canada
8 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e129
Concordance and discordance between policymaker and family physician experiences of the COVID-19-driven rise of virtual care in Nova Scotia
Aim: To describe and understand areas of concordance and discordance between the perceptions and experiences of family physicians and policymakers regarding the implementation and use of virtual care within the Nova Scotian primary care system. Background: COVID-19 brought rapid change to primary care delivery and accessibility. Virtual care rapidly expanded, facilitating primary care access amidst public health restrictions. Health systems leaders facilitated access to virtual care, developed and implemented guidelines, and created new billing codes. Providers integrated virtual care and operation changes into practice. Methods: Semi-structured interviews with family physicians ( n = 20), policymakers ( n = 9) and a family physician/policymaker ( n = 1) were conducted to understand virtual care implementation and outcomes in Nova Scotia, Canada, identifying benefits and challenges. Findings: All participants discussed patient confidentiality concerns, overreliance potential, and virtual care to promote patient care access. Family physicians discussed provider privacy and burnout. Policymakers discussed virtual care increasing capacity for accepting new patients and challenges evaluating virtual care billing codes. Providers and policymakers shared concerns and policy directions for development and expansion of virtual care. As there is little research from policymaker perspectives on virtual care, reconciling these viewpoints is crucial for effectiveness and sustainability.
- 22 October 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e129
Open AccessConcordance and discordance between policymaker and family physician experiences of the COVID-19-driven rise of virtual care in Nova Scotia
Aim: To describe and understand areas of concordance and discordance between the perceptions and experiences of family physicians and policymakers regarding the implementation and use of virtual care within the Nova Scotian primary care system. Background: COVID-19 brought rapid change to primary care delivery and accessibility. Virtual care rapidly expanded, facilitating primary care access amidst public health restrictions. Health systems leaders facilitated access to virtual care, developed and implemented guidelines, and created new billing codes. Providers integrated virtual care and operation changes into practice. Methods: Semi-structured interviews with family physicians ( n = 20), policymakers ( n = 9) and a family physician/policymaker ( n = 1) were conducted to understand virtual care implementation and outcomes in Nova Scotia, Canada, identifying benefits and challenges. Findings: All participants discussed patient confidentiality concerns, overreliance potential, and virtual care to promote patient care access. Family physicians discussed provider privacy and burnout. Policymakers discussed virtual care increasing capacity for accepting new patients and challenges evaluating virtual care billing codes. Providers and policymakers shared concerns and policy directions for development and expansion of virtual care. As there is little research from policymaker perspectives on virtual care, reconciling these viewpoints is crucial for effectiveness and sustainability.
- Open Access
- 16 June 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e65
‘I can contribute so much more but you have to untie my hands’ – a qualitative study of COVID-19 pandemic impacts on community pharmacist practice: lessons and future directions
Aim: The aim of our study was to understand how routine pharmacy practice was impacted during the COVID-19 pandemic and the consequences for patient access. Background: Community pharmacists are among the most accessible primary care providers, playing a vital role in primary care access for patients. During the COVID-19 pandemic, community pharmacists took on numerous additional roles to support safe primary care access. As health systems are in the latter stages of recovery from the pandemic, understanding how the pandemic impacted routine community pharmacy practice and the repercussions for post-pandemic practice is important. Methods: Between September 2020 and January 2021, we interviewed 11 pharmacists working in community pharmacies in Nova Scotia, Canada. We thematically analyzed qualitative data pertaining to pharmacists’ perceptions of pandemic impacts on providers, patients, and pharmacy practice. Findings: The COVID-19 pandemic greatly impacted community pharmacy practice, patients, and community pharmacists. Participants recommended maintaining some of the community pharmacy practice changes and suggested that continuing to expand the scope of practice for pharmacists is essential to meeting population health needs moving forward. Pharmacists recognize and are willing to maintain the essential roles they have assumed in facilitating patient access to primary care. Decision-makers should consider providing the necessary supports (e.g., communication software) and funding support to enable the full scope of community pharmacist practice.
- 16 June 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e65
Open Access‘I can contribute so much more but you have to untie my hands’ – a qualitative study of COVID-19 pandemic impacts on community pharmacist practice: lessons and future directions
Aim: The aim of our study was to understand how routine pharmacy practice was impacted during the COVID-19 pandemic and the consequences for patient access. Background: Community pharmacists are among the most accessible primary care providers, playing a vital role in primary care access for patients. During the COVID-19 pandemic, community pharmacists took on numerous additional roles to support safe primary care access. As health systems are in the latter stages of recovery from the pandemic, understanding how the pandemic impacted routine community pharmacy practice and the repercussions for post-pandemic practice is important. Methods: Between September 2020 and January 2021, we interviewed 11 pharmacists working in community pharmacies in Nova Scotia, Canada. We thematically analyzed qualitative data pertaining to pharmacists’ perceptions of pandemic impacts on providers, patients, and pharmacy practice. Findings: The COVID-19 pandemic greatly impacted community pharmacy practice, patients, and community pharmacists. Participants recommended maintaining some of the community pharmacy practice changes and suggested that continuing to expand the scope of practice for pharmacists is essential to meeting population health needs moving forward. Pharmacists recognize and are willing to maintain the essential roles they have assumed in facilitating patient access to primary care. Decision-makers should consider providing the necessary supports (e.g., communication software) and funding support to enable the full scope of community pharmacist practice.
- Open Access
- 3 April 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (3)
Implementing the screening for poverty and related social determinants and intervening to improve knowledge of and links to resources (SPARK) in primary care clinics across Canada
Background: Routine systematic collection of social determinants data can inform improvements to health service delivery and system and policy planning. Objective: This cohort study reports on the implementation of the SPARK tool to collect and integrate demographic and social needs data in primary care. Methods: The 20-question SPARK tool was implemented from September 2022 to October 2023 at five primary care clinics. Implementation was evaluated using the following outcomes: acceptability, appropriateness, adoption, feasibility, fidelity, cost, penetration, and sustainability. Data included: clinic checklists (n = 5), training evaluations (n = 33), SPARK tool responses (n = 2063), patient surveys (n = 1368), and provider and staff surveys (n = 36). Survey responses were analyzed using frequency (%) and mean (SD). Open-ended responses were analyzed to identify key themes. Results: There was strong acceptability and adoption of the tool. Collection methods contributed to variation in perceived relevance, compatibility and barriers. Among patients, 90.5% indicated the tool was clear and easy to complete, and 84.5% had a positive experience. A minority of patients (7.8%) indicated difficulty answering ≥1 question on SPARK. Among clinic staff and providers, 96.7% reported the tool was useful, and 81.8% had a positive experience. Clinics highlighted concerns with resource allocation and suggested adjustments to collection, integration, and personnel to support implementation. Conclusions: The SPARK tool is acceptable and feasible for adoption in primary care clinics. This study provides practical insight into implementing demographic and social needs data collection, including adaptations to clinic workflows, enhanced integration platforms, and supports that ensure the sustainability of social needs screening in primary care.
- 3 April 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (3)
Open AccessImplementing the screening for poverty and related social determinants and intervening to improve knowledge of and links to resources (SPARK) in primary care clinics across Canada
Background: Routine systematic collection of social determinants data can inform improvements to health service delivery and system and policy planning. Objective: This cohort study reports on the implementation of the SPARK tool to collect and integrate demographic and social needs data in primary care. Methods: The 20-question SPARK tool was implemented from September 2022 to October 2023 at five primary care clinics. Implementation was evaluated using the following outcomes: acceptability, appropriateness, adoption, feasibility, fidelity, cost, penetration, and sustainability. Data included: clinic checklists (n = 5), training evaluations (n = 33), SPARK tool responses (n = 2063), patient surveys (n = 1368), and provider and staff surveys (n = 36). Survey responses were analyzed using frequency (%) and mean (SD). Open-ended responses were analyzed to identify key themes. Results: There was strong acceptability and adoption of the tool. Collection methods contributed to variation in perceived relevance, compatibility and barriers. Among patients, 90.5% indicated the tool was clear and easy to complete, and 84.5% had a positive experience. A minority of patients (7.8%) indicated difficulty answering ≥1 question on SPARK. Among clinic staff and providers, 96.7% reported the tool was useful, and 81.8% had a positive experience. Clinics highlighted concerns with resource allocation and suggested adjustments to collection, integration, and personnel to support implementation. Conclusions: The SPARK tool is acceptable and feasible for adoption in primary care clinics. This study provides practical insight into implementing demographic and social needs data collection, including adaptations to clinic workflows, enhanced integration platforms, and supports that ensure the sustainability of social needs screening in primary care.
- Open Access
Understanding Canadian experiences of suicidality during the COVID-19 pandemic: protocol of a pan-Canadian qualitative study
Introduction The COVID-19 pandemic led to major disruptions in society across many spheres, including healthcare, the economy and social behaviours. While early predictions warned of an increased risk of suicide during and after the COVID-19 pandemic, rates of suicide deaths remained stable or decreased over that period for most countries. In contrast, the prevalence of suicidal ideation doubled and suicide attempts slightly increased during the COVID-19 pandemic in the adult general population worldwide, accompanied by a higher prevalence of major depressive disorder and anxiety disorders. While these data can tell us what happened, they cannot tell us why. Qualitative suicide research seeks to understand experiences of individuals with suicide-related thoughts and behaviours, provides an in-depth exploration of their lives and interactions with others and centres their views and unique context. There is little qualitative research focusing on suicidality during the pandemic. This study will use a qualitative approach to explore the extent and impact of the COVID-19 pandemic on Canadians who experienced suicidality and review their experiences of accessing mental healthcare to identify key components in supporting safety and recovery. Methods and analysis This study will involve approximately 100 semistructured interviews with participants across four Canadian provinces and will explore experiences with suicide-related thoughts and behaviours during the COVID-19 pandemic. Transcripts will be analysed through qualitative analysis informed by constructivist grounded theory. Ethics and dissemination The study was approved by the Research Ethics Board of the Centre for Addiction and Mental Health, Toronto Academic Health Sciences Network (for JZ: CAMH REB No 104-2022). In addition to traditional peer-reviewed presentations and publications, a report will make study findings accessible to policy makers, media and the public.
Open AccessUnderstanding Canadian experiences of suicidality during the COVID-19 pandemic: protocol of a pan-Canadian qualitative study
Introduction The COVID-19 pandemic led to major disruptions in society across many spheres, including healthcare, the economy and social behaviours. While early predictions warned of an increased risk of suicide during and after the COVID-19 pandemic, rates of suicide deaths remained stable or decreased over that period for most countries. In contrast, the prevalence of suicidal ideation doubled and suicide attempts slightly increased during the COVID-19 pandemic in the adult general population worldwide, accompanied by a higher prevalence of major depressive disorder and anxiety disorders. While these data can tell us what happened, they cannot tell us why. Qualitative suicide research seeks to understand experiences of individuals with suicide-related thoughts and behaviours, provides an in-depth exploration of their lives and interactions with others and centres their views and unique context. There is little qualitative research focusing on suicidality during the pandemic. This study will use a qualitative approach to explore the extent and impact of the COVID-19 pandemic on Canadians who experienced suicidality and review their experiences of accessing mental healthcare to identify key components in supporting safety and recovery. Methods and analysis This study will involve approximately 100 semistructured interviews with participants across four Canadian provinces and will explore experiences with suicide-related thoughts and behaviours during the COVID-19 pandemic. Transcripts will be analysed through qualitative analysis informed by constructivist grounded theory. Ethics and dissemination The study was approved by the Research Ethics Board of the Centre for Addiction and Mental Health, Toronto Academic Health Sciences Network (for JZ: CAMH REB No 104-2022). In addition to traditional peer-reviewed presentations and publications, a report will make study findings accessible to policy makers, media and the public.
- Open Access
Validation of a standardised approach to collect sociodemographic and social needs data in Canadian primary care: cross-sectional study of the SPARK tool
Objective This study validates the previously tested Screening for Poverty And Related social determinants to improve Knowledge of and access to resources (‘SPARK Tool’) against comparison questions from well-established national surveys (Post Survey Questionnaire (PSQ)) to inform the development of a standardised tool to collect patients’ demographic and social needs data in healthcare. Design Cross-sectional study. Setting Pan-Canadian study of participants from four Canadian provinces (SK, MB, ON and NL). Participants 192 participants were interviewed concurrently, completing both the SPARK tool and PSQ survey. Main outcomes Survey topics included demographics: language, immigration, race, disability, sex, gender identity, sexual orientation; and social needs: education, income, medication access, transportation, housing, social support and employment status. Concurrent validity was performed to assess agreement and correlation between SPARK and comparison questions at an individual level as well as within domain clusters. We report on Cohen’s kappa measure of inter-rater reliability, Pearson correlation coefficient and Cramer’s V to assess overall capture of needs in the SPARK and PSQ as well as within each domain. Agreement between the surveys was described using correct (true positive and true negative) and incorrect (false positive and false negative) classification. Results There was a moderate correlation between SPARK and PSQ (0.44, p60), SPARK correctly classified 90.5% (n=176/191). Conclusions SPARK provides a brief 15 min screening tool for primary care clinics to capture social and access needs. SPARK was able to correctly classify most participants within each domain. Related ongoing research is needed to further validate SPARK in a large representative sample and explore primary care implementation strategies to support integration.
Open AccessValidation of a standardised approach to collect sociodemographic and social needs data in Canadian primary care: cross-sectional study of the SPARK tool
Objective This study validates the previously tested Screening for Poverty And Related social determinants to improve Knowledge of and access to resources (‘SPARK Tool’) against comparison questions from well-established national surveys (Post Survey Questionnaire (PSQ)) to inform the development of a standardised tool to collect patients’ demographic and social needs data in healthcare. Design Cross-sectional study. Setting Pan-Canadian study of participants from four Canadian provinces (SK, MB, ON and NL). Participants 192 participants were interviewed concurrently, completing both the SPARK tool and PSQ survey. Main outcomes Survey topics included demographics: language, immigration, race, disability, sex, gender identity, sexual orientation; and social needs: education, income, medication access, transportation, housing, social support and employment status. Concurrent validity was performed to assess agreement and correlation between SPARK and comparison questions at an individual level as well as within domain clusters. We report on Cohen’s kappa measure of inter-rater reliability, Pearson correlation coefficient and Cramer’s V to assess overall capture of needs in the SPARK and PSQ as well as within each domain. Agreement between the surveys was described using correct (true positive and true negative) and incorrect (false positive and false negative) classification. Results There was a moderate correlation between SPARK and PSQ (0.44, p60), SPARK correctly classified 90.5% (n=176/191). Conclusions SPARK provides a brief 15 min screening tool for primary care clinics to capture social and access needs. SPARK was able to correctly classify most participants within each domain. Related ongoing research is needed to further validate SPARK in a large representative sample and explore primary care implementation strategies to support integration.
- Open Access
- 7 August 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1038
Primary health care provider availability and accessibility: a comparison of responses from providers and their office staff, results from the Models and Access Atlas of Primary Care – Nova Scotia (MAAP-NS) population study
Primary care providers’ (i.e., physicians and nurse practitioners) perceptions of their availability and accessibility may differ from those of their staff (i.e., clerical or reception staff), who are the gatekeepers to accessing care. The objective of this study is to compare responses of primary care providers and their staff on questions reflecting provider availability and accessibility. We conducted a population survey within Nova Scotia Canada that included 369 primary health care providers and their staff. Main outcomes measured included whether primary health care providers were accepting new patients, requiring meet-and-greets before accepting new patients, had a one-issue-per-visit policy, and had weekly office-hours. Among providers, 87% reported accepting new patients whereas only 64% of their staff said that they do (p < 0.001). Rates of unconditionally accepting patients (11% of providers and 10% of staff) did not differ (p = 0.62). Acceptance of opioid-requiring patients was reported by 61% of providers and by 70% of their staff (p = 0.05). Requiring meet-and-greets was reported by 36% of providers and 52% of their staff (p < 0.001). There was no difference on a one-issue-per-visit policy (15% of providers and 16% of staff; p = 0.75). The median (IQR) number of hours per week spent working as an office-based primary care provider was 40 (30, 45) reported by the providers and 28.9 (21, 35) reported by staff (p < 0.001). Discrepancies between providers and staff when describing the same practices suggests that components of availability and accessibility are not uniformly understood. Staff who deal with members of the public seeking a provider may inaccurately indicate a provider’s acceptance of new patients, identifying a need for improved specific communication between providers and their staff.
- 7 August 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1038
Open AccessPrimary health care provider availability and accessibility: a comparison of responses from providers and their office staff, results from the Models and Access Atlas of Primary Care – Nova Scotia (MAAP-NS) population study
Primary care providers’ (i.e., physicians and nurse practitioners) perceptions of their availability and accessibility may differ from those of their staff (i.e., clerical or reception staff), who are the gatekeepers to accessing care. The objective of this study is to compare responses of primary care providers and their staff on questions reflecting provider availability and accessibility. We conducted a population survey within Nova Scotia Canada that included 369 primary health care providers and their staff. Main outcomes measured included whether primary health care providers were accepting new patients, requiring meet-and-greets before accepting new patients, had a one-issue-per-visit policy, and had weekly office-hours. Among providers, 87% reported accepting new patients whereas only 64% of their staff said that they do (p < 0.001). Rates of unconditionally accepting patients (11% of providers and 10% of staff) did not differ (p = 0.62). Acceptance of opioid-requiring patients was reported by 61% of providers and by 70% of their staff (p = 0.05). Requiring meet-and-greets was reported by 36% of providers and 52% of their staff (p < 0.001). There was no difference on a one-issue-per-visit policy (15% of providers and 16% of staff; p = 0.75). The median (IQR) number of hours per week spent working as an office-based primary care provider was 40 (30, 45) reported by the providers and 28.9 (21, 35) reported by staff (p < 0.001). Discrepancies between providers and staff when describing the same practices suggests that components of availability and accessibility are not uniformly understood. Staff who deal with members of the public seeking a provider may inaccurately indicate a provider’s acceptance of new patients, identifying a need for improved specific communication between providers and their staff.
- Open Access
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings
Introduction: SARS-CoV-2 is now endemic and expected to remain a health threat, with new variants continuing to emerge and the potential for vaccines to become less effective. While effective vaccines and natural immunity have significantly reduced hospitalisations and the need for critical care, outpatient treatment options remain limited, and real-world evidence on their clinical and cost-effectiveness is lacking. In this paper, we present the design of the Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID). By evaluating multiple treatment options in a pragmatic adaptive platform trial, this study will generate high-quality, generalisable evidence to inform clinical guidelines and healthcare decision-making. Methods and analysis: CanTreatCOVID is an open-label, individually randomised, multicentre, national adaptive platform trial designed to evaluate the clinical and cost-effectiveness of therapeutics for non-hospitalised SARS-CoV-2 patients across Canada. Eligible participants must present with symptomatic SARS-CoV-2 infection, confirmed by PCR or rapid antigen testing (RAT), within 5 days of symptom onset. The trial targets two groups that are expected to be at higher risk of more severe disease: (1) individuals aged 50 years and older and (2) those aged 18–49 years with one or more comorbidities. CanTreatCOVID uses numerous approaches to recruit participants to the study, including a multifaceted public communication strategy and outreach through primary care, outpatient clinics and emergency departments. Participants are randomised to receive either usual care, including supportive and symptom-based management, or an investigational therapeutic selected by the Canadian COVID-19 Outpatient Therapeutics Committee. The first therapeutic arm evaluates nirmatrelvir/ritonavir (Paxlovid), administered two times per day for 5 days. The second therapeutic arm investigates a combination antioxidant therapy (selenium 300 µg, zinc 40 mg, lycopene 45 mg and vitamin C 1.5 g), administered for 10 days. The primary outcome is all-cause hospitalisation or death within 28 days of randomisation. Ethics and dissemination: The CanTreatCOVID master protocol and subprotocols have been approved by Health Canada and local research ethics boards in the participating provinces across Canada. The results of the study will be disseminated to policy-makers, presented at conferences and published in peer-reviewed journals to ensure that findings are accessible to the broader scientific and medical communities. This study was approved by the Unity Health Toronto Research Ethics Board (#22-179) and Clinical Trials Ontario (Project ID 4133). Trial registration number: NCT05614349
Open AccessCanadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings
Introduction: SARS-CoV-2 is now endemic and expected to remain a health threat, with new variants continuing to emerge and the potential for vaccines to become less effective. While effective vaccines and natural immunity have significantly reduced hospitalisations and the need for critical care, outpatient treatment options remain limited, and real-world evidence on their clinical and cost-effectiveness is lacking. In this paper, we present the design of the Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID). By evaluating multiple treatment options in a pragmatic adaptive platform trial, this study will generate high-quality, generalisable evidence to inform clinical guidelines and healthcare decision-making. Methods and analysis: CanTreatCOVID is an open-label, individually randomised, multicentre, national adaptive platform trial designed to evaluate the clinical and cost-effectiveness of therapeutics for non-hospitalised SARS-CoV-2 patients across Canada. Eligible participants must present with symptomatic SARS-CoV-2 infection, confirmed by PCR or rapid antigen testing (RAT), within 5 days of symptom onset. The trial targets two groups that are expected to be at higher risk of more severe disease: (1) individuals aged 50 years and older and (2) those aged 18–49 years with one or more comorbidities. CanTreatCOVID uses numerous approaches to recruit participants to the study, including a multifaceted public communication strategy and outreach through primary care, outpatient clinics and emergency departments. Participants are randomised to receive either usual care, including supportive and symptom-based management, or an investigational therapeutic selected by the Canadian COVID-19 Outpatient Therapeutics Committee. The first therapeutic arm evaluates nirmatrelvir/ritonavir (Paxlovid), administered two times per day for 5 days. The second therapeutic arm investigates a combination antioxidant therapy (selenium 300 µg, zinc 40 mg, lycopene 45 mg and vitamin C 1.5 g), administered for 10 days. The primary outcome is all-cause hospitalisation or death within 28 days of randomisation. Ethics and dissemination: The CanTreatCOVID master protocol and subprotocols have been approved by Health Canada and local research ethics boards in the participating provinces across Canada. The results of the study will be disseminated to policy-makers, presented at conferences and published in peer-reviewed journals to ensure that findings are accessible to the broader scientific and medical communities. This study was approved by the Unity Health Toronto Research Ethics Board (#22-179) and Clinical Trials Ontario (Project ID 4133). Trial registration number: NCT05614349
- Open Access
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
The Intersection of Policy and Health Equity in Primary Health Care: A Policy Scan of 3 Canadian Provinces
Introduction/Objectives: Health equity is increasingly being recognized as an important aspect of healthcare. A focus on health equity allows everyone to reach their full potential. Yet there are gaps in healthcare to address health equity. The aim of this Canadian study was to assess how policy facilitates and hinders health equity within team-based primary healthcare settings in 3 provinces: British Columbia (BC), Ontario (ON), and Nova Scotia (NS), identify the similarities and differences across the Canadian provinces, and provide recommendations and actions to advance health equity at policy and systems levels. Methods: We used the OPTIC-PHC conceptual framework developed by the study team to better understand the implementation of primary healthcare teams. The Systemic Equity Action-Analysis Framework was used as the theoretical foundation for the work. The study used a policy scan approach to identify, review, and analyze primary healthcare policy documents in the 3 participating provinces. Sixty-two documents were included in the study. Results: Health equity did not appear in policy documents consistently until 2018. Four key themes were identified in the policy scan: partner engagement; Community Health Centres, Indigenous health, and equity initiatives. Conclusions: Health equity is now much more prevalent in policy documents. What is unknown, is whether equity approaches/initiatives have been implemented and/or evaluated. There is significant opportunity for collaboration between patients, caregivers, community members, healthcare providers, decision-makers, and policy-makers to develop health equity initiatives, to implement clearly articulated principles and initiatives to drive health equity, and to measure outcomes of these initiatives in primary healthcare settings.
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Open AccessThe Intersection of Policy and Health Equity in Primary Health Care: A Policy Scan of 3 Canadian Provinces
Introduction/Objectives: Health equity is increasingly being recognized as an important aspect of healthcare. A focus on health equity allows everyone to reach their full potential. Yet there are gaps in healthcare to address health equity. The aim of this Canadian study was to assess how policy facilitates and hinders health equity within team-based primary healthcare settings in 3 provinces: British Columbia (BC), Ontario (ON), and Nova Scotia (NS), identify the similarities and differences across the Canadian provinces, and provide recommendations and actions to advance health equity at policy and systems levels. Methods: We used the OPTIC-PHC conceptual framework developed by the study team to better understand the implementation of primary healthcare teams. The Systemic Equity Action-Analysis Framework was used as the theoretical foundation for the work. The study used a policy scan approach to identify, review, and analyze primary healthcare policy documents in the 3 participating provinces. Sixty-two documents were included in the study. Results: Health equity did not appear in policy documents consistently until 2018. Four key themes were identified in the policy scan: partner engagement; Community Health Centres, Indigenous health, and equity initiatives. Conclusions: Health equity is now much more prevalent in policy documents. What is unknown, is whether equity approaches/initiatives have been implemented and/or evaluated. There is significant opportunity for collaboration between patients, caregivers, community members, healthcare providers, decision-makers, and policy-makers to develop health equity initiatives, to implement clearly articulated principles and initiatives to drive health equity, and to measure outcomes of these initiatives in primary healthcare settings.
- Open Access
- 6 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e52244
Perspectives on Using Artificial Intelligence to Derive Social Determinants of Health Data From Medical Records in Canada: Large Multijurisdictional Qualitative Study
Background: Data on the social determinants of health could be used to improve care, support quality improvement initiatives, and track progress toward health equity. However, this data collection is not widespread. Artificial intelligence (AI), specifically natural language processing and machine learning, could be used to derive social determinants of health data from electronic medical records. This could reduce the time and resources required to obtain social determinants of health data. Objective: This study aimed to understand perspectives of a diverse sample of Canadians on the use of AI to derive social determinants of health information from electronic medical record data, including benefits and concerns. Methods: Using a qualitative description approach, in-depth interviews were conducted with 195 participants purposefully recruited from Ontario, Newfoundland and Labrador, Manitoba, and Saskatchewan. Transcripts were analyzed using an inductive and deductive content analysis. Results: A total of 4 themes were identified. First, AI was described as the inevitable future, facilitating more efficient, accessible social determinants of health information and use in primary care. Second, participants expressed concerns about potential health care harms and a distrust in AI and public systems. Third, some participants indicated that AI could lead to a loss of the human touch in health care, emphasizing a preference for strong relationships with providers and individualized care. Fourth, participants described the critical importance of consent and the need for strong safeguards to protect patient data and trust. Conclusions: These findings provide important considerations for the use of AI in health care, and particularly when health care administrators and decision makers seek to derive social determinants of health data.
- 6 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e52244
Open AccessPerspectives on Using Artificial Intelligence to Derive Social Determinants of Health Data From Medical Records in Canada: Large Multijurisdictional Qualitative Study
Background: Data on the social determinants of health could be used to improve care, support quality improvement initiatives, and track progress toward health equity. However, this data collection is not widespread. Artificial intelligence (AI), specifically natural language processing and machine learning, could be used to derive social determinants of health data from electronic medical records. This could reduce the time and resources required to obtain social determinants of health data. Objective: This study aimed to understand perspectives of a diverse sample of Canadians on the use of AI to derive social determinants of health information from electronic medical record data, including benefits and concerns. Methods: Using a qualitative description approach, in-depth interviews were conducted with 195 participants purposefully recruited from Ontario, Newfoundland and Labrador, Manitoba, and Saskatchewan. Transcripts were analyzed using an inductive and deductive content analysis. Results: A total of 4 themes were identified. First, AI was described as the inevitable future, facilitating more efficient, accessible social determinants of health information and use in primary care. Second, participants expressed concerns about potential health care harms and a distrust in AI and public systems. Third, some participants indicated that AI could lead to a loss of the human touch in health care, emphasizing a preference for strong relationships with providers and individualized care. Fourth, participants described the critical importance of consent and the need for strong safeguards to protect patient data and trust. Conclusions: These findings provide important considerations for the use of AI in health care, and particularly when health care administrators and decision makers seek to derive social determinants of health data.
- Open Access
Examining experiences and system impacts of publicly funded episodic virtual care: protocol for a cross-provincial mixed methods study
Introduction: Health systems are under pressure as one in five Canadians have no regular place for primary care, with many experiencing substantial travel times and delays in accessing care. In the context of these urgent needs, platforms for virtual care offer immediate access to care in ‘walk-in’ style format, with limited continuity for ongoing health needs or coordination with other health services. We refer to these services as episodic virtual care (EVC), to distinguish them from virtual services offered in longitudinal primary care. The governments of Nova Scotia (NS) and New Brunswick (NB) both offer publicly funded EVC and offer a unique opportunity for research. The overarching goal of this work is to learn from the implementation of EVC in NS and NB to understand experiences and system impacts, including What are patient perceptions and experiences of EVC and how do these differ by patient characteristics? What are the characteristics of patients who use EVC and of clinicians who deliver it? What are the system impacts of EVC? Methods and analysis: We will use a cross-sectional survey conducted through an online questionnaire to explore patient perceptions and experiences with EVC. We will also examine how these differ based on the type of care needed, age, gender, residence (urban or rural), immigration and language preference. We will use linked administrative data and quasi-experimental analysis to assess the impacts of EVC on visits to community-based primary care (including in-person walk-in clinics), emergency department visits, prescriptions and referrals for other health services like laboratory testing, imaging and consulting specialist physicians. Ethics and dissemination: This proposal has been reviewed and received approval from the Nova Scotia Health Research Ethics Board. Findings will identify the impacts and trade-offs in the deployment of EVC, which will inform primary care planning. In addition to traditional academic publications and information provided to primary care patients/the public, this study will inform decision-makers across multiple jurisdictions as they contend with the challenge of meeting patients’ immediate care needs for access to primary care, while seeking to improve coordination and integration of systems as a whole.
Open AccessExamining experiences and system impacts of publicly funded episodic virtual care: protocol for a cross-provincial mixed methods study
Introduction: Health systems are under pressure as one in five Canadians have no regular place for primary care, with many experiencing substantial travel times and delays in accessing care. In the context of these urgent needs, platforms for virtual care offer immediate access to care in ‘walk-in’ style format, with limited continuity for ongoing health needs or coordination with other health services. We refer to these services as episodic virtual care (EVC), to distinguish them from virtual services offered in longitudinal primary care. The governments of Nova Scotia (NS) and New Brunswick (NB) both offer publicly funded EVC and offer a unique opportunity for research. The overarching goal of this work is to learn from the implementation of EVC in NS and NB to understand experiences and system impacts, including What are patient perceptions and experiences of EVC and how do these differ by patient characteristics? What are the characteristics of patients who use EVC and of clinicians who deliver it? What are the system impacts of EVC? Methods and analysis: We will use a cross-sectional survey conducted through an online questionnaire to explore patient perceptions and experiences with EVC. We will also examine how these differ based on the type of care needed, age, gender, residence (urban or rural), immigration and language preference. We will use linked administrative data and quasi-experimental analysis to assess the impacts of EVC on visits to community-based primary care (including in-person walk-in clinics), emergency department visits, prescriptions and referrals for other health services like laboratory testing, imaging and consulting specialist physicians. Ethics and dissemination: This proposal has been reviewed and received approval from the Nova Scotia Health Research Ethics Board. Findings will identify the impacts and trade-offs in the deployment of EVC, which will inform primary care planning. In addition to traditional academic publications and information provided to primary care patients/the public, this study will inform decision-makers across multiple jurisdictions as they contend with the challenge of meeting patients’ immediate care needs for access to primary care, while seeking to improve coordination and integration of systems as a whole.